Skip to main content
. 2014 Jan 23;7(4):977–981. doi: 10.3892/etm.2014.1496

Figure 1.

Figure 1

Response of the patients to the initial VTD treatment and the bortezomib-based retreatment. VTD, bortezomib, thalidomide and dexamethasone; CR, complete response; VGPR, very good partial response; PR, partial response; NR, no response.